VitaNova Life Sciences Corporation revenue by segment VNOV

VitaNova Life Sciences Corporation splits its revenue into 4 lines in its filings. The largest line in fiscal 2026, which ended Apr 30, 2026 was Dietary Supplement at $1.9 million, 64% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2027
Jul 31, 2026
FY 2026
Apr 30, 2026
FY 2025
Apr 30, 2025
FY 2024
Apr 30, 2024
FY 2023
Apr 30, 2023
FY 2022
Apr 30, 2022
FY 2021
Apr 30, 2021
FY 2020
Apr 30, 2020
FY 2019
Apr 30, 2019
FY 2018
Apr 30, 2018
Revenue
3
3
3
1
0
0
0
0
0
0
Dietary Supplement
—
2
-26.5%
share 64.4%
3
+386.8%
share 99.6%
1
share 95.4%
—
—
—
—
—
—
Food Products
—
1
share 35.1%
—
—
—
—
—
—
—
—
Other
—
0
share 0.5%
—
—
—
—
—
—
—
—
Consulting Service
—
—
0
-58.5%
share 0.4%
0
-31.3%
share 4.6%
0
share 100.0%
—
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Wholesale-Apparel, Piece Goods & Notions (SIC 5130)
Listed as
VNOV (OTC)
Fiscal year ends
April 30
Incorporated in
NV
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1699709
Former names
YIJIA GROUP CORP. (until Jan 13, 2026); YIJIA GROUP CORP (until Jul 29, 2019); Soldino Group Corp (until Nov 26, 2018)

Other Wholesale-Apparel, Piece Goods & Notions companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.